111In-HMFG1-F(ab')2

N/A

Report date: 2025/10/10 14:30:17

NME

Base Information

Drug Name111In-HMFG1-F(ab')2

Drug Alias Name111In-labeled HMFG1 F(ab')2

ClassificationRadiation-emitting products > Nuclides > Indium > 111InRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Radionuclide Drug Conjugates

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsCarcinoma, Non-Small-Cell Lung

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited Kingdom

CombinationsNo

Global Highest StatusPending (Clinical)

Highest Status in ChinaN/A

Originator CompaniesHammersmith Hospital

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesHammersmith Hospital

Active IndicationsN/A

Inactive IndicationsCarcinoma, Non-Small-Cell Lung

Other Information

ATC CodeN/A